Hitachi Medical Corporation and Redlen Technologies have announced an agreement to collaborate on the development of a direct conversion semiconductor x-ray detector module to be used with photon-counting CT (PCCT) systems.

Hitachi will have exclusive access to the technology once development is complete.

“PCCT is a promising next generation device which achieves radiation exposure reduction, high functionality and high degree of precision. It is expected to broaden the field of application,” Masaya Watanabe, Hitachi vice president and executive officer, president and CEO of healthcare group and healthcare company, said in a prepared statement. “I hope this agreement will provide opportunities for us to further contribute to healthcare innovation.”

“We are excited to partner with Hitachi, one of the original pioneers of medical CT technology, to pursue the enormous potential for advancement in medical CT that photon counting semiconductor sensors offer,” Glenn Bindley, Redlen Technologies president and CEO, said in the same statement.